Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1984 Jun;44(3):695–701. doi: 10.1128/iai.44.3.695-701.1984

Growth-inhibitory and bactericidal effects of human parotid salivary histidine-rich polypeptides on Streptococcus mutans.

B J MacKay, L Denepitiya, V J Iacono, S B Krost, J J Pollock
PMCID: PMC263672  PMID: 6724693

Abstract

Growth inhibition and cell viability assays demonstrate that the histidine-rich polypeptides isolated from human parotid saliva are bacteriostatic and bactericidal for strains of Streptococcus mutans belonging to the serotype b and c classifications. Both inhibition of growth and cell division are enhanced by preincubation of bacteria with these polypeptides in low-ionic-strength buffers of acidic and neutral pH before dilution into enriched growth media. With prior exposure at pH 6.8, inhibition by these polypeptides of the serotype c strains, S. mutans GS5 and SB, as well as the serotype b strain, S. mutans BHT, is reversible over time under the experimental conditions selected. With similar exposure at pH 5.2, however, irreversible damage is manifested by complete inhibition of both growth and cell viability. At concentrations of 250 micrograms of the mixture of histidine-rich polypeptides per 5 X 10(5) bacterial cells per ml in the acidic preincubation buffer, bacterial lethality is maintained for a period of 48 h in the enriched growth media. At a 50-micrograms/ml concentration of these salivary agents, approximately 80% killing of S. mutans SB is noted after a 24-h incubation; however, surviving bacteria multiply and reach turbidities of untreated control cells when examined at the 48-h growth point. Similarly, hen egg white lysozyme is also found to be bactericidal for these microorganisms when preincubation is carried out under acidic conditions. However, in contrast to the histidine-rich polypeptides, lysozyme under these experimental conditions does not inhibit growth of S. mutans SB at neutral pH, although it does inhibit growth of both S. mutans BHT and S. mutans GS5 at this pH. Preexposure of S. mutans SB to the peptides in buffer at ionic strengths of 0.025 to 0.125, followed by either viability assays under nongrowing conditions or growth inhibition studies, suggests that there is very little effect of ionic strength on the antibacterial function of these peptides. In contrast to the inhibition of viability noted under growing conditions, lower concentrations of the histidine-rich polypeptides were required to elicit immediate cell death under nongrowing conditions.

Full text

PDF
695

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azen E. A. Genetic protein polymorphisms in human saliva: an interpretive review. Biochem Genet. 1978 Feb;16(1-2):79–99. doi: 10.1007/BF00484386. [DOI] [PubMed] [Google Scholar]
  2. BURGER W. C., STAHMANN M. A. The agglutination and growth inhibition of bacteria by lysine polypeptides. Arch Biochem Biophys. 1952 Jul;39(1):27–36. doi: 10.1016/0003-9861(52)90257-9. [DOI] [PubMed] [Google Scholar]
  3. Balekjian A. Y., Meyer T. S., Montague M. E., Longton R. W. Electrophoretic patterns of parotid fluid proteins from caries-resistant and caries-susceptible individuals. J Dent Res. 1975 Jul-Aug;54(4):850–856. doi: 10.1177/00220345750540042501. [DOI] [PubMed] [Google Scholar]
  4. Baum B. J., Bird J. L., Millar D. B., Longton R. W. Studies on histidine-rich polypeptides from human parotid saliva. Arch Biochem Biophys. 1976 Dec;177(2):427–436. doi: 10.1016/0003-9861(76)90455-0. [DOI] [PubMed] [Google Scholar]
  5. Cho M. I., Holt S. C., Iacono V. J., Pollock J. J. Effects of lysozyme and inorganic anions on the morphology of Streptococcus mutans BHT: electron microscopic examination. J Bacteriol. 1982 Sep;151(3):1498–1507. doi: 10.1128/jb.151.3.1498-1507.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. GIBBONS R. J. BACTERIOLOGY OF DENTAL CARIES. J Dent Res. 1964 Nov-Dec;43:SUPPL–SUPPL:1028. doi: 10.1177/00220345640430060301. [DOI] [PubMed] [Google Scholar]
  7. Gennaro R., Dolzani L., Romeo D. Potency of bactericidal proteins purified from the large granules of bovine neutrophils. Infect Immun. 1983 May;40(2):684–690. doi: 10.1128/iai.40.2.684-690.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Goodell E. W., Lopez R., Tomasz A. Suppression of lytic effect of beta lactams on Escherichia coli and other bacteria. Proc Natl Acad Sci U S A. 1976 Sep;73(9):3293–3297. doi: 10.1073/pnas.73.9.3293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Goodman H., Pollock J. J., Iacono V. J., Wong W., Shockman G. D. Peptidoglycan loss during hen egg white lysozyme-inorganic salt lysis of Streptococcus mutans. J Bacteriol. 1981 May;146(2):755–763. doi: 10.1128/jb.146.2.755-763.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Goodman H., Pollock J. J., Katona L. I., Iacono V. J., Cho M. I., Thomas E. Lysis of Streptococcus mutans by hen egg white lysozyme and inorganic sodium salts. J Bacteriol. 1981 May;146(2):764–774. doi: 10.1128/jb.146.2.764-774.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. HIRSCH J. G. Bactericidal action of histone. J Exp Med. 1958 Dec 1;108(6):925–944. doi: 10.1084/jem.108.6.925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hartmann R., Bock-Hennig S. B., Schwarz U. Murein hydrolases in the envelope of Escherichia coli. Properties in situ and solubilization from the envelope. Eur J Biochem. 1974 Jan 3;41(1):203–208. doi: 10.1111/j.1432-1033.1974.tb03261.x. [DOI] [PubMed] [Google Scholar]
  13. Hay D. I. Fractionation of human parotid salivary proteins and the isolation of an histidine-rich acidic peptide which shows high affinity for hydroxyapatite surfaces. Arch Oral Biol. 1975 Sep;20(9):553–558. doi: 10.1016/0003-9969(75)90073-4. [DOI] [PubMed] [Google Scholar]
  14. Hebeler B. H., Young F. E. Mechanism of autolysis of Neisseria gonorrhoeae. J Bacteriol. 1976 Jun;126(3):1186–1193. doi: 10.1128/jb.126.3.1186-1193.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Holbrook I. B., Molan P. C. The identification of a peptide in human parotid saliva particularly active in enhancing the glycolytic activity of the salivary micro-organisms. Biochem J. 1975 Aug;149(2):489–492. doi: 10.1042/bj1490489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Iacono V. J., MacKay B. J., DiRienzo S., Pollock J. J. Selective antibacterial properties of lysozyme for oral microorganisms. Infect Immun. 1980 Aug;29(2):623–632. doi: 10.1128/iai.29.2.623-632.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kitano K., Tomasz A. Triggering of autolytic cell wall degradation in Escherichia coli by beta-lactam antibiotics. Antimicrob Agents Chemother. 1979 Dec;16(6):838–848. doi: 10.1128/aac.16.6.838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kreusser W., Heidland A., Hennemann H., Wigand M. E., Knauf H. Mono- and divalent electrolyte patterns, pCO 2 and pH in relation to flow rate in normal human parotid saliva. Eur J Clin Invest. 1972 Nov;2(6):398–406. doi: 10.1111/j.1365-2362.1972.tb00668.x. [DOI] [PubMed] [Google Scholar]
  19. Kuramitsu S., Ikeda K., Hamaguchi K., Miwa S., Nakashima K. Binding of N-acetyl-chitotriose to human lysozyme. J Biochem. 1975 Aug;78(2):327–333. doi: 10.1093/oxfordjournals.jbchem.a130911. [DOI] [PubMed] [Google Scholar]
  20. MacKay B. J., Iacono V. J., Zuckerman J. M., Osserman E. F., Pollock J. J. Quantitative recovery, selective removal and one-step purification of human parotid and leukemic lysozymes by immunoadsorption. Eur J Biochem. 1982 Dec;129(1):93–98. doi: 10.1111/j.1432-1033.1982.tb07025.x. [DOI] [PubMed] [Google Scholar]
  21. MacKay B. J., Pollock J. J., Iacono V. J., Baum B. J. Isolation of milligram quantities of a group of histidine-rich polypeptides from human parotid saliva. Infect Immun. 1984 Jun;44(3):688–694. doi: 10.1128/iai.44.3.688-694.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Miller B. F., Abrams R., Dorfman A., Klein M. ANTIBACTERIAL PROPERTIES OF PROTAMINE AND HISTONE. Science. 1942 Nov 6;96(2497):428–430. doi: 10.1126/science.96.2497.428. [DOI] [PubMed] [Google Scholar]
  23. Miller T. E., Watson D. W. Biochemical characterization of the antimicrobial histone released by deoxyribonuclease and lactic acid. Proc Soc Exp Biol Med. 1969 Jun;131(2):339–342. doi: 10.3181/00379727-131-33873. [DOI] [PubMed] [Google Scholar]
  24. Modrzakowski M. C., Cooney M. H., Martin L. E., Spitznagel J. K. Bactericidal activity of fractionated granule contents from human polymorphonuclear leukocytes. Infect Immun. 1979 Mar;23(3):587–591. doi: 10.1128/iai.23.3.587-591.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Odeberg H., Olsson I. Mechanisms for the microbicidal activity of cationic proteins of human granulocytes. Infect Immun. 1976 Dec;14(6):1269–1275. doi: 10.1128/iai.14.6.1269-1275.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Olsson I., Venge P. Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid cells. Blood. 1974 Aug;44(2):235–246. [PubMed] [Google Scholar]
  27. Payne J. Damage and recovery in streptococci. Soc Appl Bacteriol Symp Ser. 1978;7:349–369. [PubMed] [Google Scholar]
  28. Perch B., Kjems E., Ravn T. Biochemical and serological properties of Streptococcus mutans from various human and animal sources. Acta Pathol Microbiol Scand B Microbiol Immunol. 1974 Jun;82(3):357–370. doi: 10.1111/j.1699-0463.1974.tb02338.x. [DOI] [PubMed] [Google Scholar]
  29. Peters E. H., Azen E. A. Isolation and partial characterization of human parotid basic proteins. Biochem Genet. 1977 Oct;15(9-10):925–946. doi: 10.1007/BF00483989. [DOI] [PubMed] [Google Scholar]
  30. Peters E. H., Goodfriend T., Azen E. A. Human Pb, human post-Pb, and nonhuman primate Pb proteins: immunological and biochemical relationships. Biochem Genet. 1977 Oct;15(9-10):947–962. doi: 10.1007/BF00483990. [DOI] [PubMed] [Google Scholar]
  31. Rest R. F., Cooney M. H., Spitznagel J. K. Susceptibility of lipopolysaccharide mutants to the bactericidal action of human neutrophil lysosomal fractions. Infect Immun. 1977 Apr;16(1):145–151. doi: 10.1128/iai.16.1.145-151.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. SKARNES R. C., WATSON D. W. Antimicrobial factors of normal tissues and fluids. Bacteriol Rev. 1957 Dec;21(4):273–294. doi: 10.1128/br.21.4.273-294.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. SPITZNAGEL J. K. Antibacterial effects associated with changes in bacterial cytology produced by cationic polypeptides. J Exp Med. 1961 Dec 1;114:1079–1091. doi: 10.1084/jem.114.6.1079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Shockman G. D., Higgins M. L., DaneoMoore L., Mattingly S. J., Diersio J. R., Terleckyj B. Studies of balanced and unblaanced growth of Streptococcus mutans. J Dent Res. 1976 Jan;55:A10–A18. doi: 10.1177/002203457605500101011. [DOI] [PubMed] [Google Scholar]
  35. Terleckyj B., Willett N. P., Shockman G. D. Growth of several cariogenic strains of oral streptococci in a chemically defined medium. Infect Immun. 1975 Apr;11(4):649–655. doi: 10.1128/iai.11.4.649-655.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Tomasz A. From penicillin-binding proteins to the lysis and death of bacteria: a 1979 view. Rev Infect Dis. 1979 May-Jun;1(3):434–467. doi: 10.1093/clinids/1.3.434. [DOI] [PubMed] [Google Scholar]
  37. Walton E., Gladstone G. P. Factors affecting the susceptibility of staphylococci to killing by the cationic proteins from rabbit polymorphonuclear leucocytes: the effects of alteration of cellular energetics and of various iron compounds. Br J Exp Pathol. 1976 Oct;57(5):560–570. [PMC free article] [PubMed] [Google Scholar]
  38. Wecke J., Lahav M., Ginsburg I., Giesbrecht P. Cell wall degradation of Staphylococcus aureus by lysozyme. Arch Microbiol. 1982 Mar;131(2):116–123. doi: 10.1007/BF01053992. [DOI] [PubMed] [Google Scholar]
  39. Weiss J., Elsbach P., Olsson I., Odeberg H. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem. 1978 Apr 25;253(8):2664–2672. [PubMed] [Google Scholar]
  40. Wilkens T. J., Goodman H., MacKay B. J., Iacono V. J., Pollock J. J. Bacteriolysis of Streptococcus mutans GS5 by lysozyme, proteases, and sodium thiocyanate. Infect Immun. 1982 Dec;38(3):1172–1180. doi: 10.1128/iai.38.3.1172-1180.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES